Our results that treatment of COLO 320 DM cells with 25 uM EPA increased the sensitivity to 5-Fluorouracil in the CD133 (+) cells suggests instead that adjuvant therapy with EPA combined with 5-Fluorouracil could be a viable therapeutic option for colon cancer patients. The gene discussed is PROM1; the disease is colonic neoplasm.